【结 构 式】 |
【分子编号】65269 【品名】 【CA登记号】 |
【 分 子 式 】C22H29NO7 【 分 子 量 】419.4748 【元素组成】C 62.99% H 6.97% N 3.34% O 26.7% |
合成路线1
该中间体在本合成路线中的序号:(VIIIa)Condensation of (1S,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl tosylate (I) with 3(R)-benzyloxypyrrolidine (II) provides vernakalant benzyl ether (III), which is then debenzylated by catalytic hydrogenolysis over Pd/C (1). In a more direct approach, tosylate (I) is condensed with 3(R)-hydroxypyrrolidine (IV) to provide vernakalant (1, 2). An alternative strategy consists of the cyclization of (1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexylamine (V) with (R )-2-acetoxysuccinic anhydride (VI) by means of acetyl chloride or with ethyl 4-chloro-3(R )-hydroxybutyrate (VII) to give, respectively, the cyclic imide (VIIIa) or the pyrrolidinone (VIIIb), which is subsequently reduced and deprotected by means of Red-Al to yield the title hydroxypyrrolidine derivative (2). The O-benzyl precursor of vernakalant (III) can alternatively be obtained by condensation of 2(R )-[3(R )-benzyloxy-1-pyrrolidinyl]cyclohexan-1(R )-ol (IX) with 3,4-dimethoxyphenethyl trichloroacetimidate (X) (prepared from dimethoxyphenethyl alcohol [XI] and trichloroacetonitrile) in the presence of trifluoromethanesulfonic acid (2, 3). A related strategy for preparing the succinimide precursor of vernakalant (VIIIa) consists of the condensation of 2(R)-acetoxy-N-[2(R)-hydroxy-1(R)-cyclohexyl]succinimide (XII) with imidate (X) in the presence of boron trifluoride etherate (4). Scheme 1.
【1】 Beatch, G.N., Choi, L.S.L., Jung, G. et al. (Cardiome Pharma Corp.). Aminocyclohexyl ether compounds and uses thereof. EP 1560812, EP1666459, JP 2006525227, WO 2004099137. |
【2】 Plouvier, B.M.C., Chou, D.T.H., Jung, G. et al. (Cardiome Pharma Corp.). Synthetic process for aminocyclohexyl ether compounds. WO 2006088525. |
【3】 Machiya, K., Ike, K., Watanabe, M., Yoshino, T., Okamoto, T., Morinaga, Y., Mizobata, S. (Astellas Pharma, Inc.). Production method of optically active cyclohexane ether compounds. WO 2006075778. |
【4】 Roth, C.J., Jung, G., Plouvier, B.M.C., Chou, D.T.H., Yee, J.G.K. (Cardiome Pharma Corp.). Synthetic processes for the preparation of aminocyclohexyl ether compounds. WO 2006138673. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIIIa) | 65269 | C22H29NO7 | 详情 | 详情 | ||
(VIIIb) | 65270 | C20H29NO5 | 详情 | 详情 | ||
(I) | 65263 | (1S,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl tosylate | C23H30O6S | 详情 | 详情 | |
(II) | 65264 | (3R)-benzyloxypyrrolidine | C11H15NO | 详情 | 详情 | |
(III) | 65265 | vernakalant benzyl ether | C27H37NO4 | 详情 | 详情 | |
(IV) | 14490 | (3R)tetrahydro-1H-pyrrol-3-ol; R-3-hydroxypyrrolidine | 2799-21-5 | C4H9NO | 详情 | 详情 |
(V) | 65266 | (1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexylamine | C16H25NO3 | 详情 | 详情 | |
(VI) | 65267 | (2R)-acetoxysuccinic anhydride | 79814-40-7 | C6H6O5 | 详情 | 详情 |
(VII) | 65268 | ethyl 4-chloro-(3R)-hydroxybutyrate; | 90866-33-4 | C6H11ClO3 | 详情 | 详情 |
(IX) | 65271 | (2R)-[(3R)-benzyloxy-1-pyrrolidinyl]cyclohexan-(1R)-ol | C16H25NO2 | 详情 | 详情 | |
(X) | 65272 | 3,4-dimethoxyphenethyl trichloroacetimidate | C12H14Cl3NO3 | 详情 | 详情 | |
(XI) | 38711 | 2-(3,4-dimethoxyphenyl)-1-ethanol | 7417-21-2 | C10H14O3 | 详情 | 详情 |
(XII) | 65273 | (2R)-acetoxy-N-[(2R)-hydroxy-(1R)-cyclohexyl]succinimide | C12H17O5 | 详情 | 详情 |